Decisions 26th June 2018

At the meeting on the 26th June the following decisions were agreed

New Drug Requests


Ketotifen eye drops

  • Approved for inclusion onto the formulary for seasonal allergic conjunctivitis as an alternative option to olopatadine or when a preservative free option is needed.

Aprokam® Cefuroxime injection

  • Approved for inclusion onto the formulary for prophylaxis of post-operative endophthalmitis during cataract surgery.

Lecicarbon A

  • Approved for inclusion onto the formulary for chronic constipation pending an adult constipation pathway

Shared Care Protocols

Sacubitril/valsartan (entresto)

  • Updated SCP agreed


  • Amended SCP presented for amantadine for the management of fatigue in patients diagnosed with multiple sclerosis.  The group decided a separate SCP for amantadine for this indication was needed. 


  • Further information regarding contraception needed then SCP to be uploaded.

Other items

  • All new amber SCPs to be 3 months initially.
  • Decision making tool for change of traffic light status discussed, to be amended and trialed at the next JFG.



Last updated by: Tash Mogford on 06-08-2018 14:20